Welcome to the new morningstar.co.uk! Learn more about the changes and how our new features help your investing success.

Immunodiagnostic Systems Expects 2% Rise In Interim Revenue

(Alliance News) - Immunodiagnostic Systems Holdings PLC on Friday said it expects to see an ...

Alliance News 18 October, 2019 | 6:14PM
Email Form

(Alliance News) - Immunodiagnostic Systems Holdings PLC on Friday said it expects to see an increase in first-half revenue following positive momentum during the period.

For the half year ended September 30, group revenue is set to come in at GBP18.8 million, 2% higher than the same period last year. On a like for like basis, revenue is expected to be in line with the same period last year, the company noted.

Revenue from the company's Automated business remained unchanged from last year, with growth in speciality assays offsetting declining 25-OH Vitamin D sales.

In terms of outlook, the company said based on the positive momentum seen in the first half, it maintained its financial 2020 target of delivering increased full year revenue on a like-for-like basis versus financial 2019.

The automated diagnostic testing kits provider is slated to report interim results on November 22.

The stock closed up 7.4% at 290 pence in London on Friday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Immunodiagnostic Systems Holdings PLC 279.00 GBX -0.36 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites